Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | APLNR | P35414 | 1/20 | 0.33 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3641879 | 1.00 | BTK (0.46) | BTKHRH3HSD17B10POLBMAPK1 | |
| SCHEMBL28473594 | 1.00 | BTK (0.46) | BTKHRH3HSD17B10POLBMAPK1 | |
| SCHEMBL1298062 | 0.91 | HRH3 (0.43) | BTKHRH3MAPK1CHRM2CHRM1 | |
| SCHEMBL20928664 | 0.91 | BTK (0.41) | BTKHRH3HSD17B10POLBMAPK1 | |
| SCHEMBL26181859 | 0.85 | BTK (0.45) | BTKHRH3HSD17B10MAPK1CHRM2 | |
| SCHEMBL16671305 | 0.84 | BTK (0.41) | BTKHRH3HSD17B10POLBMAPK1 | |
| SCHEMBL1296379 | 0.84 | BTK (0.61) | BTKHRH3HSD17B10CHRM2CHRM1 | |
| SCHEMBL10328238 | 0.83 | HRH3 (0.46) | BTKHRH3HSD17B10POLBMAPK1 | |
| SCHEMBL4220147 | 0.83 | CHRNB2 (0.48) | BTKHRH3MAPK1CHRM2CHRM1 | |
| SCHEMBL3643983 | 0.83 | CHRNB2 (0.48) | BTKHRH3MAPK1CHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355020-A | Therapeutic compounds for HIV virus infection | 吉利德科学公司 | 2024-07-16 | — | — | CN | disclosed |
| US-20230203071-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | GILEAD SCIENCES, INC. | 2023-06-29 | — | — | US | disclosed |
| US-8889748-B2 | Process for producing expandable styrene polymer compositions | BASF SE (DE) | 2014-11-18 | — | — | US | disclosed |
| US-8535436-B2 | Use of cyclohexane polycarboxylic acid derivatives for removing dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-09-17 | — | — | US | disclosed |
| US-8454744-B2 | Use of polyols and cyclohexane polycarboxylic acid derivatives for the removal of dust from chemical construction products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| US-20120138206-A1 | ADHESIVES AND SEALANTS CONTAINING CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES | BASF SE (DE) | 2012-06-07 | — | — | US | disclosed |
| US-20110291040-A1 | PROCESS FOR PRODUCING EXPANDABLE STYRENE POLYMER COMPOSITIONS | BASF SE (DE) | 2011-12-01 | — | — | US | disclosed |
| US-20110265693-A1 | Use Of Polyols And Cyclohexane Polycarboxylic Acid Derivatives For The Removal Of Dust From Chemical Construction Products | Construction Research & Tecnology GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110232825-A1 | CYCLOHEXANE POLYCARBOXYLIC ACID DERIVATIVES AS PLASTICIZERS FOR ADHESIVES AND SEALANTS | BASF SE (DE) | 2011-09-29 | — | — | US | disclosed |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2011-09-01 | — | — | US | disclosed |
| US-7337913-B2 | Single piece closure device made of PVC | BASF AKTIENGESELLSCHAFT (DE) | 2008-03-04 | — | — | US | disclosed |
| US-20050106405-A1 | Single piece closure device made of pvc | BASF AKTIENGESELLSCHAFT (DE) | 2005-05-19 | — | — | US | disclosed |
| US-6683030-B2 | CONTAINING A CYCLOHEXANEPOLYCARBOXYLIC ACID ESTER, ESPECIALLY A DIISOALKYL 1,2-CYCLOHEXANEDICARBOXYLATE; A NONIONIC SURFACTANT; WATER; AND AN ACTIVE PLANT TREATMENT AGENT, E.G, HERBICIDE OR PLANT GROWTH REGULATOR | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-27 | — | — | US | disclosed |
| US-20030069135-A1 | Agrotechnical formulation | BASF AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069135-A1 | Agrotechnical formulation | HACL2, CBR1, ACACA | BTK 4854/4885HRH3 757/4885HSD17B10 78/4885 |
| US-20110209644-A1 | Use of Cyclohexane Polycarboxylic Acid Derivatives For Removing Dust From Chemical Construction Products | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HPD, HCAR2 | BTK 4869/4885HRH3 1251/4885HSD17B10 1555/4885 |
| US-20230203071-A1 | THERAPEUTIC COMPOUNDS FOR HIV VIRUS INFECTION | HAVCR2, MAVS, CD4 | BTK 2515/4885HRH3 2598/4885HSD17B10 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.